The triple-negative breast cancer (TNBC) exhibit negative expression for estrogen receptor (ER), progesterone receptor (PR) as well as human epidermal growth factor receptor 2 (HER-2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.